Edwards Lifesciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
02 Enero 2024 - 8:00AM
Business Wire
Edwards Lifesciences Corporation (NYSE: EW) today announced it
will participate in the J.P. Morgan Healthcare Conference on
Tuesday, Jan. 9, 2024.
Bernard Zovighian, chief executive officer, is scheduled to
present at 11:15 a.m. PT. Scott Ullem, chief financial officer,
will also participate in the conference. A live webcast of the
presentation will be available on the Edwards Lifesciences investor
relations website at http://ir.edwards.com/, with an archived
version accessible later the same day.
About Edwards
Lifesciences
Edwards Lifesciences is the global leader of patient-focused
innovations for structural heart disease and critical care
monitoring. We are driven by a passion for patients, dedicated to
improving and enhancing lives through partnerships with clinicians
and stakeholders across the global healthcare landscape. For more
information, visit Edwards.com and follow us on Facebook,
Instagram, LinkedIn, Twitter and YouTube.
Edwards, Edwards Lifesciences, and the stylized E logo are
trademarks of Edwards Lifesciences Corporation. All other
trademarks are the property of their respective owners.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240102605074/en/
Media Contact: Amy Hytowitz, 949-250-5070 Investor Contact: Mark
Wilterding, 949-250-6826
Edwards Lifesciences (NYSE:EW)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Edwards Lifesciences (NYSE:EW)
Gráfica de Acción Histórica
De May 2023 a May 2024